Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
2.759
-0.041 (-1.48%)
Mar 4, 2026, 10:19 AM EST - Market open
Polaryx Therapeutics Market Cap
Polaryx Therapeutics has a market cap or net worth of $130.6 million as of March 4, 2026.
Market Cap
130.60M
Enterprise Value
126.82M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since February 2, 2026, Polaryx Therapeutics's market cap has decreased from $1.66B to $130.60M, a decrease of -92.12%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 132.56M | -2.78% |
| Mar 2, 2026 | 136.35M | -5.57% |
| Feb 27, 2026 | 144.40M | -4.39% |
| Feb 26, 2026 | 151.03M | 15.16% |
| Feb 25, 2026 | 131.14M | -1.07% |
| Feb 24, 2026 | 132.56M | 13.36% |
| Feb 23, 2026 | 116.94M | -5.36% |
| Feb 20, 2026 | 123.57M | -2.25% |
| Feb 19, 2026 | 126.41M | -7.61% |
| Feb 18, 2026 | 136.82M | -27.02% |
| Feb 17, 2026 | 187.48M | 64.32% |
| Feb 13, 2026 | 114.10M | -17.47% |
| Feb 12, 2026 | 138.24M | -19.34% |
| Feb 11, 2026 | 171.38M | -19.56% |
| Feb 10, 2026 | 213.04M | -24.11% |
| Feb 9, 2026 | 280.75M | -33.45% |
| Feb 6, 2026 | 421.83M | -44.31% |
| Feb 5, 2026 | 757.49M | -28.89% |
| Feb 4, 2026 | 1.07B | 2.51% |
| Feb 3, 2026 | 1.04B | -37.29% |
| Feb 2, 2026 | 1.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 150.22M |
| Artiva Biotherapeutics | 141.62M |
| Connect Biopharma Holdings | 139.76M |
| Adagene | 139.51M |
| Black Diamond Therapeutics | 138.45M |
| Immunic | 138.29M |
| Oramed Pharmaceuticals | 132.94M |
| Cardiff Oncology | 132.63M |